Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Unique Cancer Survivors' Summit Unites Patients From Across the Nation to Celebrate Life

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 11 /- More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their Proleukin® (aldesleukin for injection) treatment experiences.  The theme of the meeting, Celebrating Our (Un)Common Journey...

Kaiser Permanente Leads the Nation in 12 Quality Measures

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

OAKLAND, Calif., Oct. 11 /- Kaiser Permanente leads the nation among all reporting commercial health plans with top marks in 12 quality measures. These conclusions were based on information in the 2010 National Committee for Quality Assurance's Quality Compass® data. Kaiser...

Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

MARQUETTE, Mich., Oct. 11 /- Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to establish a manufacturing and distribution facility in Ireland.  Pioneer has initiated discussions with the IDA (Ireland Development...

Advertisement

Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors

October 11, 2010 11:31 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Oct. 11 /- Apollo Endosurgery, Inc. announced completion of the first clinical case involving its FlexShears™ Endoscopic Scissors.  The new device was used to cut and remove an obstructing eroded suture from the patient's GI tract in a procedure that embodies the...

Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors' Orders

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Oct. 11 /- Through a set of proprietary computer models, Express Scripts, Inc. (Nasdaq: ESRX ), is now able to accurately predict up to a year in advance which patients are most at risk of falling off their physician-prescribed drug therapy — and to intervene in...

Arable Corporation Announces New Technology for Clinical Trial Industry

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Oct. 11 /- Arable Corporation ( www.arablecorp.com ) has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry.  Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS...

TriReme Medical Announces $17 Million Series D Financing

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Oct. 11 /- TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing.  The financing was led by Bio*One Capital, a subsidiary of Singapore based...

Varian Medical Systems and Stanford University Win $3.6 Million Five-Year NIH/NCI Research Grant to Develop Advanced Imaging Technology

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Oct. 11 /- Scientists from Stanford University and from the Ginzton Technology Center at Varian Medical Systems have jointly received a $3.6 million five-year research grant from the U.S. National Institutes of Health (NIH) to develop advanced imaging technology...

Advertisement

Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc® Radiotherapy from Varian Medical Systems

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, and PALO ALTO, Calif., Oct. 11 /- Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while...

MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

DALLAS and NEW YORK, Oct. 11 /- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP ), a biopharmaceutical company specializing in products for cancer and supportive care, announced the highlights from a poster presentation on European clinical experience of MuGard at this year's...

DATATRAK Awarded Three Phase III Studies

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Oct. 11 /- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing...

DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients

October 11, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Oct. 11 /- The preeminent law office of Nurenberg, Paris, Heller & McCarthy has filed a class action lawsuit against Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc., on behalf of clients who suffered damages resulting from the company's...

IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery

October 11, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 11 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company's laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser...

Advertisement

Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer

October 11, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Oct. 11 /- Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the German Cancer Research Center (DKFZ) announced today that they have entered into a research collaboration to enable more specific prediction of a woman's risk for developing cervical cancer....

Executive Profile

October 10, 2010 11:31 pm | by San Diego Business Journal | News | Comments

Bradley A. Marcus, a doctor of osteopathic medicine, is the founder and operator of Medical Rehabilitation & Kinematics Lab. He is board-certified by the American Board of Medical Specialties in the field of physical medicine and rehabilitation.

Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®

October 10, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Oct. 10 /- Amgen (Nasdaq:  AMGN) today announced results from two integrated analyses of head-to-head pivotal Phase 3 trials comparing denosumab to Zometa® (zoledronic acid), the current standard of care in the prevention of skeletal related events (SREs)...

Virginian-Pilot Story Misleads Readers on USDA Inspection Report for PLRS

October 8, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CORAPEAKE, N.C., Oct. 8 /- Contrary to a report in today's Virginian-Pilot , a comprehensive inspection by the U.S. Department of Agriculture (USDA) of NC-based Professional Laboratory and Research Services (PLRS) has found no evidence of animal neglect or abuse. The USDA finding follows...

Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia

October 8, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Oct. 8 /PRNewswire-USNewswire/ -- Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) from the U.S. market because of clinical trial data indicating an increased risk of heart attack and stroke, the U.S. Food and Drug...

Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)

October 8, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Oct. 8 /- Synapse Biomedical Inc . announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS)™ as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis ( ALS ) patients with a...

Pioneer® Surgical Technology, Inc. Announces Agreement to Acquire Exclusive Access to the Cequence™ Cervical Plate System From SpineSmith, LP

October 8, 2010 9:31 am | by Bio-Medicine.Org | News | Comments

MARQUETTE, Mich., Oct. 8 /- Pioneer Surgical Technology, Inc. and SpineSmith, LP are pleased to announce a deal in which Pioneer Surgical will acquire exclusive rights to manufacture and distribute the Cequence™ anterior cervical plate.  As part of the agreement, Pioneer...

Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call

October 8, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Oct. 8 /- Varian Medical Systems (NYSE: VAR ) announced today that it will report results for fourth quarter of fiscal year 2010 following the close of regular trading on Thursday, October 28, 2010.  The news release will be followed by a teleconference available...

3G Wireless Technology Empowers Patients to Take Control of Their Health Through the Dulce Wireless Tijuana Project

October 8, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

TIJUANA, Mexico, Oct. 8 /- Qualcomm Incorporated (Nasdaq: QCOM ), through its Wireless Reach™ initiative, today announced the launch of the Dulce Wireless Tijuana project.  The project will empower underserved communities to improve diabetes care and prevention through the use...

Concentric Medical Announces Commercial Launch of Trevo™ in Europe

October 8, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 8 /- Concentric Medical, Inc. today announced the full European launch of Trevo™, the first device utilizing Stentriever™ technology for clot retrieval in ischemic stroke patients.  Trevo is the newest offering in a portfolio of products from...

Interventional Spine®, Inc. Awarded the 2010 Best New Technology in Cervical Care Award

October 8, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 8 /- Interventional Spine®, Inc. today announced the Company's unique PERPOS® Percutaneous Cervical System has been awarded the 2010 Best New Technology in Cervical Card Award at The Orthopedics This Week® Spine Technology Awards® Gala held in...

Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results

October 7, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Oct. 7 /- Boston Scientific Corporation (NYSE: BSX ) will webcast its conference call discussing financial results for the third quarter ended September 30, 2010 on Tuesday, October 19, at 5:30 p.m. ET.  The timing of the call was set to avoid conflicts with previously...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading